Product Program year 2019 Source: CMS Open Payments

Triptodur

Drug Pediatrics/Neonatology

NDC 2433-8150-20

Open in the dashboard

General payments

$36,840

584 payments

Research payments

$0

0 payments

Through program year 2019, $36,840 in general payments and $0 in research payments were reported against Triptodur (Pediatrics/Neonatology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2019 General $36,840 584

Breakdown

Who paid General payments · program year 2019
  1. Arbor Pharmaceuticals, Inc. $36,840 584 payments
Top recipients General payments · program year 2019
  1. Stelios Mantis Pediatric Endocrinology · Chicago, IL $6,670 18% · 9 payments
  2. Karen Klein Pediatric Endocrinology · San Diego, CA $5,508 15% · 13 payments
  3. Matthew Feldt Pediatric Endocrinology · Kansas City, MO $5,202 14% · 7 payments
  4. Siham Accacha Pediatric Endocrinology · Mineola, NY $4,870 13% · 5 payments
  5. Nancy Wright Pediatric Endocrinology · Tallahassee, FL $4,532 12% · 10 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Pediatric Endocrinology Pediatrics $34,203 93% · 182 practitioners
  2. Pediatrics $876 2% · 34 practitioners
  3. Endocrinology, Diabetes & Metabolism Internal Medicine $708 2% · 22 practitioners
  4. Neurological Surgery $221 <1% · 11 practitioners
  5. Pediatric Hematology-Oncology Pediatrics $140 <1% · 2 practitioners

The top 5 of 24 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Illinois $7,603 21% · 13 recipients
  2. California $7,226 20% · 41 recipients
  3. New York $5,930 16% · 30 recipients
  4. Missouri $5,737 16% · 9 recipients
  5. Florida $4,911 13% · 19 recipients

The top 5 of 37 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

584 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record